General Generative AI-driven drug Rentosertib enters Phase III trial for idiopathic pulmonary fibrosisBy Healthcare Propulsion StaffSeptember 10, 20260 Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed the first patient with…
General Rentosertib shifts multiple proteomic aging clocks toward younger age profiles in IPF trialBy Healthcare Propulsion StaffSeptember 10, 20260 Six different protein-based aging clocks tracked how an experimental IPF drug reshaped biological age signals, revealing a striking disconnect between…
